Business
Why I’d buy today’s CSL share price over Mesoblast – Motley Fool Australia
Looking to invest in an ASX biotech? As a long-term investor, here’s why I would buy today’s CSL share price rather than Mesoblast.
The Mesoblast Limited(ASX: MSB) share price has been garnering a lot of attention recently. But here’s why I would buy today’s CSL Limited(ASX: CSL) share price over Mesoblast.
The Mesoblast share price has surged more than 126% in 2020. By contrast, the CSL share price remains relatively flat for the year. Despite the disparity in share price performance, I think that CSL provides greater potential for long-term investors.
CSL and COVID-19
In my opinion, CSL is one of the highest quality com…
-
Noosa News24 hours agoLachie Neale gives himself ’50 per cent’ chance of improbable grand final appearance after calf injury
-
Noosa News10 hours agoTwo in five Brisbane streets have no footpaths, with council building about 4km of new paths last year
-
Business19 hours agoWhere to invest $20,000 in ASX ETFs for 2026 and beyond
-
General19 hours agoReece Walsh grabs the Sun to lead Brisbane to an all-time victory over Canberra